Tag: Tekcapital
Belluscura cleared to launch POC
March 9, 2021HME News Staff
LONDON — Tekcapital has announced that its portfolio company Belluscura has been granted 510(k) clearance and marketing authorization by the U.S. Food and Drug Administration for its X-PLO2R portable oxygen concentrator. "We are excited to see that the FDA has cleared the X-PLO2R device for sale, as Tekcapital and Belluscura believe it could be helpful to patients during the COVID-19 pandemic, and for many of the 250 million people worldwide suffering from COPD," said Clifford Gross, PhD, executive...
Belluscura, Food & Drug Administration (FDA), Portable Oxygen Concentrator (POC), Tekcapital
Sponsored Stories
From Intake to Billing — SOS Handles It All for HME/DME Providers
By Strategic Office SupportHow Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office Support